Some of the ongoing research directions include: Long-term safety and efficacy: As BPC-157 is a relatively new compound, long-term studies are needed to establish its safety and efficacy in various populations and for different indications
In the face of vitamin B 12 deficiency, conversion of methylmalonyl-CoA to succinyl-CoA cannot take place, which results in accumulation of methylmalonyl-CoA and aberrant fatty acid synthesis
Vitamin B12 injections, typically hydroxocobalamin in the UK, are evidence-based therapies for confirmed B12 deficiency, treating conditions such as pernicious anaemia and malabsorption syndromes
No valid prescription required (a red flag, not a benefit)
gastric juicederived tissue regenerative peptide Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids) Chemical Formula: CHNO (peptide free acid) Molecular Weight: ~1419.55 g/mol (peptide free acid)
BPC-157: The Gastric Peptide BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a protective protein found in human gastric juice